Sirion Biotech

Planegg, Germany Founded: 2005 • Age: 21 yrs Acquired By PerkinElmer
Customized AAV-based viral vectors for gene therapy are supplied.

About Sirion Biotech

Sirion Biotech is a Healthcare company based in Planegg (Germany) founded in 2005, and was acquired by PerkinElmer in June 2021. Customized AAV-based viral vectors for gene therapy are supplied. The company has 42 employees. Sirion Biotech offers products and services including Viral Vector Products, LentiBOOSTâ„¢, and AAV Capsid Development. Its focus areas include Biopharma Outsourcing, CRO, Drug Discovery and Cell and Molecular Biology. Its legal entity is SIRION BIOTECH GmbH.

Company details

Sirion Biotech was founded in 2005 in Planegg, Germany, operating in the biotechnology sector focused on viral vectors. Adenovirus, lentivirus, and AAV types are customized for genetic cell modeling, target validation, gene therapy, and vaccination studies. Services include virion modifications, multi-staged virus-driven cell modeling, and preclinical target research support. Cell modeling services are also provided to clients.

Key Metrics

Products & Services of Sirion Biotech

Sirion Biotech offers a comprehensive portfolio of products and services, including Viral Vector Products, LentiBOOST™, and AAV Capsid Development.

Viral Vector Products
Gene Delivery

Efficient vehicles for gene delivery in research purposes

LentiBOOST™
Transduction Enhancer

Improves lentiviral transduction efficiency for cell therapy

AAV Capsid Development
Vector Optimization

Enhances performance of adeno-associated virus vectors

Funding Insights of Sirion Biotech

  • Total Rounds 3
  • Last Round Grant — $493,587
  • Investors Count 6

All 3 funding rounds of Sirion Biotech with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2016$493,587Grant––
Apr 2013Seed–Bayern Kapital, Creathor Venture
–
Jun 2011Seed–Bayern Kapital, Creathor Venture
–
Valuation history

7 investors in total: 7 institutional.

Investors in Sirion Biotech

Sirion Biotech has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include PerkinElmer, European Union and KfW.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
High-tech industries are targeted for investments by Bayern Kapital.
bayernkapital.deLandshut, Germany
creathor.com
Early-stage investments are made in high-tech startups by HTGF.
htgf.deBonn, Germany
Investments are made in young technology companies by AUMENTA.
aumenta.euDüsseldorf, Germany
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Consumer and SME loans are provided across Germany.
1948kfw.deFrankfurt Am Main, Germany
Medical instruments and supplies are manufactured and provided for healthcare.
1931perkinelmer.comWaltham, United States
Premium access

Investor details for Sirion Biotech

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Sirion Biotech

5 people are tracked at Sirion Biotech (4 in leadership, 1 in team); the tracked headcount is 42.

NameRoleGroup
Dieter Lingelbach
Managing DirectorLeadership
François Vromman
Vice President, Head Of Global SalesLeadership
Dr. Christian Thirion
Founder and CEOLeadership
Yvonne Berghöfer-Hochheimer
Head Of Alliance And Program ManagementLeadership
Monserrat Vázquez Rojas
Key Account ManagerTeam
Premium access

Complete people profiles for Sirion Biotech

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Sirion Biotech

4 dated milestones of Sirion Biotech across 16 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sirion Biotech is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Grant, of $494K.
  4. Exit Acquired by PerkinElmer.

Web traffic of Sirion Biotech

Websites that share an audience with Sirion Biotech (sirion-biotech.com).

Similar websites

Websites whose visitors overlap most with Sirion Biotech. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
starbase.sysu.edu.cn
starbase.sysu.edu.cn
100%
–
cit.ligue-cancer.net
cit.ligue-cancer.net
100%
–
syntheticbio.blogspot.com
syntheticbio.blogspot.com
99%
–
exiqon.com
99%
View details
targetscan.org
targetscan.org
99%
#1,696,031–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 8 similar websites and full traffic analytics for Sirion Biotech

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 8 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sirion Biotech

Premium access

Complete news archive for Sirion Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sirion Biotech

Sirion Biotech was founded in 2005 and raised its 1st funding round 6 years after it was founded.

Sirion Biotech is headquartered in Planegg, Germany. It is registered at Planegg, Bavaria, Germany.

Sirion Biotech has 42 employees.

Sirion Biotech was founded in 2005 in Planegg, Germany, operating in the biotechnology sector focused on viral vectors. Adenovirus, lentivirus, and AAV types are customized for genetic cell modeling, target validation, gene therapy, and vaccination studies. Services include virion modifications, multi-staged virus-driven cell modeling, and preclinical target research support. Cell modeling services are also provided to clients.

Sirion Biotech offers Viral Vector Products, LentiBOOSTâ„¢, and AAV Capsid Development.

Sirion Biotech has 7 investors. Key investors include PerkinElmer, European Union, KfW, Bayern Kapital, and Creathor Venture.

Sirion Biotech operates through Sirion Biotech Gmbh.

Yes. Sirion Biotech was acquired by PerkinElmer in June 2021.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available